41 Publications
Breast Cancer Res Treat 2021 Jan 3. Epub 2021 Jan 3.
Department of Oncology, Mayo Clinic, Rochester, MN, USA.
Int J Cancer 2021 Jan 29;148(2):481-491. Epub 2020 Sep 29.
Pancreas Centre BC, Vancouver General Hospital, Vancouver, British Columbia, Canada.
Breast Cancer Res Treat 2020 08;182(3):765
Genetic Pathology Evaluation Centre and University of British Columbia, Vancouver, BC, Canada.
Cell Rep 2020 06;31(10):107745
Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address:
Mod Pathol 2020 09 29;33(9):1753-1763. Epub 2020 Apr 29.
Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC, Canada.
Oncoimmunology 2020 12;9(1):1747340. Epub 2020 Apr 12.
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
J Natl Cancer Inst 2020 Jul;112(7):737-746
Breast Cancer Res Treat 2020 Jan 14;179(1):3-10. Epub 2019 Sep 14.
Mod Pathol 2019 12 1;32(12):1772-1785. Epub 2019 Jul 1.
Cancer Immunol Res 2019 07 14;7(7):1064-1078. Epub 2019 May 14.
Department of Integrative Oncology, BC Cancer Research Centre, Vancouver, British Columbia, Canada.
Histopathology 2019 Aug 8;75(2):225-235. Epub 2019 Jul 8.
The Institute of Cancer Research, London, UK.
Int J Cancer 2019 05 6;144(10):2578-2586. Epub 2018 Dec 6.
Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, Canada.
Oncoimmunology 2018;7(11):e1502128. Epub 2018 Aug 23.
Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, Canada.
Breast Cancer Res Treat 2018 Feb 20;168(1):107-115. Epub 2017 Nov 20.
Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, 509-2660 Oak Street, Vancouver, BC, V6H 3Z6, Canada.
BMC Cancer 2017 Sep 5;17(1):618. Epub 2017 Sep 5.
Division of Anatomical Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada.
J Pathol Clin Res 2017 Jul 19;3(3):179-190. Epub 2017 Jul 19.
Pancreas Centre BCVancouverBCCanada.
JAMA Oncol 2017 Nov 9;3(11):e172085. Epub 2017 Nov 9.
Clin Cancer Res 2017 Feb 6;23(4):946-953. Epub 2016 Sep 6.
Danish Breast Cancer Cooperative Group, Copenhagen, Denmark.
Histopathology 2017 Jan 29;70(2):185-194. Epub 2016 Sep 29.
Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC, Canada.
Mod Pathol 2016 10 1;29(10):1155-64. Epub 2016 Jul 1.
Department of Pathology and Cytology GZA Hospitals, Wilrijk, Belgium.
NPJ Breast Cancer 2016 18;2:16014. Epub 2016 May 18.
Academic Department of Biochemistry, Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom.
Breast Cancer Res Treat 2016 Feb 4;155(3):483-90. Epub 2016 Feb 4.
Department of Laboratory Medicine and Pathology, University of British Columbia, 899 W 12th Ave, Vancouver, BC, V5Z 1M9, Canada.
Cell Metab 2015 Oct 10;22(4):577-89. Epub 2015 Sep 10.
Goodman Cancer Research Centre, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3A 1A3, Canada; Department of Medicine, McGill University, Montréal, QC H3A 1A3, Canada. Electronic address:
Clin Cancer Res 2015 Dec 3;21(24):5552-62. Epub 2015 Aug 3.
Takeda California, Inc., San Diego, California.
Mod Pathol 2015 Jun 20;28(6):778-86. Epub 2015 Feb 20.
Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Breast Cancer Res Treat 2015 Jan 1;149(2):439-48. Epub 2015 Jan 1.
University of British Columbia and Vancouver Coastal Health Research Institute, 2660 Oak Street, Vancouver, BC, V6H 3Z6, Canada.
Breast Cancer Res 2014 Sep 6;16(5):432. Epub 2014 Sep 6.
BMC Cancer 2014 Mar 13;14:177. Epub 2014 Mar 13.
British Columbia Cancer Agency, 3427 - 600 W 10TH Avenue, V5Z 4E6 Vancouver, BC, Canada.
J Natl Cancer Inst 2013 Dec 7;105(24):1897-906. Epub 2013 Nov 7.
Affiliations of authors: Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (MCP, LMM); Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada (SCYL, DG, EM, TON); Department of Laboratory Medicine and Pathology, University of Alberta, Alberta, Canada (JCH); Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy (MGM); Division of Pathology and Laboratory Medicine, European Institute of Oncology, and University of Milan, Milan, Italy (GV); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom (LAZ); Department of Pathology, Centre Jean Perrin, Clermont-Ferrand, and Université d'Auvergne, France (FP-L); Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB); PhenoPath Laboratories, Seattle, WA (AMG); Department of Pathology, MD Anderson Cancer Center, Houston, TX (WFS); Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom (TP); The EMMES Corporation, Rockville, MD (RAE); Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI (DFH); Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom (MD); on behalf of the International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group.
Mod Pathol 2013 Nov 24;26(11):1438-50. Epub 2013 May 24.
1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, British Columbia, Canada.